AU3877693A - Use of 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives for combating endoparasites, new 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives, and process for their preparation - Google Patents

Use of 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives for combating endoparasites, new 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives, and process for their preparation

Info

Publication number
AU3877693A
AU3877693A AU38776/93A AU3877693A AU3877693A AU 3877693 A AU3877693 A AU 3877693A AU 38776/93 A AU38776/93 A AU 38776/93A AU 3877693 A AU3877693 A AU 3877693A AU 3877693 A AU3877693 A AU 3877693A
Authority
AU
Australia
Prior art keywords
isoxazole
aryl
substituted
alkyl
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38776/93A
Other languages
English (en)
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU3877693A publication Critical patent/AU3877693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU38776/93A 1992-06-12 1993-05-24 Use of 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives for combating endoparasites, new 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives, and process for their preparation Abandoned AU3877693A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4219247 1992-06-12
DE4219247A DE4219247A1 (de) 1992-06-12 1992-06-12 Verwendung von 3-arylsubstituierten 5-Alkyl-isoxazol-4-carbonsäurederivaten zur Bekämpfung von Endoparasiten, neue 3-arylsubstituierte 5-Alkyl-isoxazol-4-carbonsäurederivate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
AU3877693A true AU3877693A (en) 1993-12-16

Family

ID=6460867

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38776/93A Abandoned AU3877693A (en) 1992-06-12 1993-05-24 Use of 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives for combating endoparasites, new 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives, and process for their preparation

Country Status (6)

Country Link
EP (1) EP0573883A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0665219A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR940000440A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU3877693A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4219247A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW221428B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365591B1 (en) 1999-10-18 2002-04-02 Recordati, S.A., Chemical And Pharmacueticals Company Isoxazolecarboxamide derivatives

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022903A1 (en) * 1994-02-25 1995-08-31 Rhone-Poulenc Agrochimie New pesticidal method
AU1758595A (en) * 1994-02-25 1995-09-11 Rhone-Poulenc Agrochimie Pesticidal method
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
ES2270482T3 (es) 1997-05-22 2007-04-01 Toyota Jidosha Kabushiki Kaisha Un dispositivo para purificar el gas de escape de un motor de combustion interna.
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
GB9919558D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
AU2001233044A1 (en) * 2000-01-28 2001-08-07 Akkadix Corporation Methods for killing nematodes and nematode eggs using bis-amino-1,2,4-thiadiazoles
EP1285914B1 (en) * 2001-08-13 2007-12-19 PheneX Pharmaceuticals AG Nr1h4 nuclear receptor binding compounds
EP1517898A1 (de) * 2002-06-29 2005-03-30 Zentaris GmbH Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und b sartiger tumorerkrankungen
AU2005245411B2 (en) * 2004-05-14 2009-04-23 Irm Llc Compounds and compositions as PPAR modulators
EP1894928A1 (en) * 2006-08-29 2008-03-05 PheneX Pharmaceuticals AG Heterocyclic fxr binding compounds
EP1894924A1 (en) * 2006-08-29 2008-03-05 Phenex Pharmaceuticals AG Heterocyclic FXR binding compounds
WO2009027393A2 (en) 2007-08-27 2009-03-05 Basf Se Pyrazole compounds for controlling invertebrate pests
US20100022590A1 (en) * 2008-01-17 2010-01-28 Biovitrum Ab (Publ.) Novel compounds
WO2009123588A1 (en) * 2008-04-01 2009-10-08 The Cleveland Clinic Foundation Amides of 3, 5-substituted-is0xaz0le-4-carb0xylic acids for the treatment of viral infections, cancer and restenosis
EA020661B1 (ru) 2008-09-24 2014-12-30 Басф Се Пиразольные соединения для борьбы с беспозвоночными вредителями
EP2416663A2 (en) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Parasiticidal formulation
US9029639B2 (en) 2009-07-06 2015-05-12 Basf Se Pyridazine compounds for controlling invertebrate pests
US8710056B2 (en) 2009-07-06 2014-04-29 Basf Se Pyridazine compounds for controlling invertebrate pests
BR112012001597A2 (pt) 2009-07-24 2015-09-01 Basf Se Método para controlar e/ou combater pestes de invertebrados, método para a proteção do material de propagação de planta e/ou das plantas que crescem do mesmo, material de propagação de planta e método para tratar ou proteger um animal de infestação ou infecção por parasitas
WO2018055235A1 (en) 2016-09-21 2018-03-29 University Of Helsinki Isoxazole-amides for treating cardiac diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3466296A (en) * 1967-05-16 1969-09-09 American Home Prod Process for the preparation of alkyl 3,5-disubstituted-isoxazole-4-carboxylates
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4034713A1 (de) * 1990-11-01 1992-05-07 Bayer Ag 3-oxy-substituierte isoxazoline, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von endoparasiten

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365591B1 (en) 1999-10-18 2002-04-02 Recordati, S.A., Chemical And Pharmacueticals Company Isoxazolecarboxamide derivatives
US6680319B2 (en) 1999-10-18 2004-01-20 Recordati S.A. Isoxazolecarboxamide derivatives

Also Published As

Publication number Publication date
EP0573883A1 (de) 1993-12-15
TW221428B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-03-01
JPH0665219A (ja) 1994-03-08
KR940000440A (ko) 1994-01-03
DE4219247A1 (de) 1993-12-16

Similar Documents

Publication Publication Date Title
AU3877693A (en) Use of 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives for combating endoparasites, new 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives, and process for their preparation
AU634424B2 (en) Use of substituted 2-mercaptonicotinic acid derivatives for combating endoparasites, new substituted 2-mercaptonicotinic acid derivatives and processes for their preparation
AU6194894A (en) Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AU623512B2 (en) Phenyl pyrimidone derivatives, processes for their preparation, and their use therapeutic agents
AU7562296A (en) Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
AU4715796A (en) Use of carotinoids for preparing medicaments for treating dermatoses
AU1473795A (en) Process for the preparation of clavulanic acid
AU3020595A (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments
AU2617692A (en) Novel acylals of imidazole-5-carboxylic acid derivatives, process for their preparation and their use
AU5768490A (en) Use of 3-hydroxybenzothiophenes for combating endoparasites, new 3-hydroxybenzothiophenes and processes for their preparation
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU6108386A (en) New process for the preparation of sphingosine derivatives
AU3548093A (en) Use of 3-amino-substituted isoxazole derivatives for combating endoparasites, new 3-amino-substituted isoxazole derivatives, and processes for their preparation
AU1530195A (en) Halogenated derivatives of 2,3'-(o)-cyclocytidine compounds and process for production thereof
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU1739392A (en) Use of 6(7)-amino-substituted quinoline-5, 8-quinones for combating endoparasites, new 6(7)-amino- substituted quinoline-5, 8-quinones and processes for their preparation
AU9142091A (en) Process for the preparation of derivatives of 3,5-dihydroxy pentanoic acid
AU6311790A (en) Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
AU3673293A (en) Process for the preparation of cinnamic acid derivatives
AU8251891A (en) Process for the preparation of 1-alkylisoquinoline derivatives
AU7291096A (en) Process for the preparation of anti-malarial drugs
HUP9602324A3 (en) Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them
HRP960076B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds, as well as medicaments containing them
AU5067590A (en) New bronchospasmolytic compounds and process for their preparation
ZA891058B (en) Use of sulphur-containing n-organooxycarbamic acid esters for combating endoparasites,new n-organooxycarbamic acid esters and processes for their preparation